Aprea Therapeutics logo
Aprea Therapeutics APRE
$ 2.92 1.13%

Quarterly report 2024-Q3
added 11-07-2024

report update icon

Aprea Therapeutics EBITDA per Share 2011-2024 | APRE

Annual EBITDA per Share Aprea Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-4.27 -68.4 -35.2 0.03 -4.89 - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
0.03 -68.4 -22.5

Quarterly EBITDA per Share Aprea Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- - -0.75 - - - -1.42 - -2.42 -86.9 - - - - - - - - - - 0.01 - - - 0.01 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
0.01 -86.9 -15.2